Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease

Sponsor
Chinese PLA General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05677607
Collaborator
(none)
300
1
60
5

Study Details

Study Description

Brief Summary

The present study aims at verifying the mutual effects between intracranial large artery atherosclerosis and cerebral small vessel disease on disease progression and prognosis by magnetic resonance imaging, and providing biomarkers for the early prevention and treatment of cerebrovascular disease.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Magnetic resonance imaging

Detailed Description

Cerebrovascular disease is the most common cause of death worldwide. There is a close link in structure and function between the intracranial large arteries and cerebral small vessels. Moreover, growing evidences have demonstrated that large artery atherosclerosis often coexists with small vessel disease, which may deteriorate the clinical outcomes of stroke and dementia. The mutual feedback mechanism between them is not fully understood. The present study focuses on the mechanism of mutual feedback between large artery atherosclerosis and cerebral small vessel disease by using magnetic resonance imaging. The study may provide biomarkers for the early prevention and treatment of cerebrovascular disease.

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2027
Anticipated Study Completion Date :
Dec 31, 2027

Arms and Interventions

Arm Intervention/Treatment
Intracranial atherosclerosis and small vessel disease

Patients diagnosed with intracranial large artery atherosclerosis and cerebral small vessel disease based on imaging screening.

Diagnostic Test: Magnetic resonance imaging
Imaging diagnostics mainly based on Magnetic resonance imaging.

Outcome Measures

Primary Outcome Measures

  1. Progression in total cerebral small vessel disease burden [1-3 YEARS]

    Total cerebral small vessel disease burden is assessed according to a sum of scores of white matter hyperintensity, cerebral microbleeds, lacunes and enlarged perivasular spaces on magnetic resonance imaging sequences.

  2. Frequency of stroke recurrence [1-3 YEARS]

    The percentage of symptomatic participants who suffer from stroke recurrence after enrollment in the territory of the targeted stenotic vessel.

Secondary Outcome Measures

  1. Frequency of stroke of asymptomatic participants [1-3 YEARS]

    The percentage of asymptomatic participants who suffer from stroke after enrollment in the territory of the targeted stenotic vessel.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • At least one intracranial artery ≥ 50% atherosclerotic stenosis

  • Modified Rankin Scale < 2

  • Mini-mental State Examination > 24

Exclusion Criteria:
  • Concurrent ipsilateral extracranial artery ≥ 50% stenosis

  • Pregnant women

  • Contraindications to magnetic resonance examination (patients with pacemakers, nerve stimulators, artificial metal heart valves and other metal foreign bodies)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chinese PLA General Hospital Beijing Beijing China 100853

Sponsors and Collaborators

  • Chinese PLA General Hospital

Investigators

  • Principal Investigator: Jinhao Lyu, Chinese PLA General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jinhao Lyu, Attending physician, Chinese PLA General Hospital
ClinicalTrials.gov Identifier:
NCT05677607
Other Study ID Numbers:
  • 301Brainmax
First Posted:
Jan 10, 2023
Last Update Posted:
Jan 10, 2023
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jinhao Lyu, Attending physician, Chinese PLA General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2023